Safe Handling and Storage Primer for Peptide Prescriptions
FDA has warned sellers that injected products bypass some defenses against germs and toxins. Storage rules vary by medicine; check its label. Here is what federal pharmacy rules and drug labels say about vials, needles, cold packs, and health checks.
Keeping Germs Out and Tracking When a Vial Was Opened
Everyday Denver SceneYou come home on a warm afternoon in Denver to find a box on the sunny porch, and the vial inside looks cloudy.
Sterile means free of living germs. USP Chapter 797 sets minimum standards for preparing sterile medicines, and FDA warns that poor compounding can cause contamination. In the 2012 New England Compounding Center meningitis outbreak, tainted steroid shots sickened 753 patients and caused 64 deaths across 20 states.
USP means United States Pharmacopeia, a group that sets medicine standards. Chapter 797 covers the preparation of sterile medicines: medicines made free of germs. It sets pharmacy standards, not a test to do at home. For vials holding more than one dose, FDA generally recommends disposal within 28 days of first use. That applies even if medicine remains or the compounder suggests longer.
NIH’s MedlinePlus says semaglutide pens belong in the fridge at 36°F to 46°F. Do not freeze them. By contrast, unopened tesamorelin (Egrifta SV) boxes stay at room temp between 68°F and 77°F, so always check your FDA package insert. FDA advises against using an injectable GLP-1 drug that arrives warm or without enough refrigeration. Ask the pharmacist about any concern with a vial.
Read the exact medicine label and the pharmacy’s directions. Some medicines need a fridge and others stay at room temperature.
Check the label before storing a pen.
Ask the pharmacist how to check the vial before use.
If a delivered GLP-1 injection is warm or did not have adequate cooling, FDA says to leave it unused.
Syringe units are not the same as milligrams on the medicine label.
Ask the pharmacist to show the exact mark on your syringe for your prescribed amount.
Mark the date of the first needle puncture on a vial used for more than one dose.
Put used needles in a proper sharps container. Never throw them away loose.
Why Syringe Units and Milligrams Cause Dosing Mistakes
Everyday Denver SceneYou open a package where the vial lists strength in milligrams, while the bag of syringes is marked in units.
FDA’s dose-error alert describes mistakes while measuring medicine from multi-dose semaglutide vials. By May 31, 2026, the FDA had received 990 reports of problems after compounded semaglutide and more than 730 after compounded tirzepatide. Reports cannot prove the medicine caused harm. The FDA says these events are likely underreported because ordinary pharmacies need not submit them.
FDA received reports of people taking 5-fold to 20-fold too much compounded semaglutide. Some dosing-error reports involved hospital stays. Confusion between syringe units and the medicine’s milligrams contributed to mistakes. Ask your pharmacist to explain your prescription and syringe; this guide gives no conversion. FDA says used needles go straight into a proper sharps container. Loose needles do not belong in household trash or recycling.
Medical Precautions, Pregnancy Timelines, and Reporting Problems
Everyday Denver SceneYou plan to start a family next year and also have a knee surgery scheduled this fall.
Semaglutide and tirzepatide labels carry a boxed warning about thyroid C-cell tumors. A boxed warning is a serious alert set apart on the label. The tumors occurred in rodent studies; whether they occur in humans is unknown. A rare inherited condition, MEN 2, rules out use under the labels; so does medullary thyroid cancer in your own or your family’s medical history. They also rule out use after a serious allergic reaction to the drug or its ingredients. Ask the clinician to check unclear family cancer history. The Wegovy and Zepbound labels warn about pancreas, gallbladder, and kidney problems. Their labels warn that stomach contents may enter the lungs during general anesthesia or deep sedation, when medicine makes you deeply asleep for a procedure. This is called lung aspiration. Tell your procedure team which drug you use and ask for their instructions.
In January 2026 the FDA asked makers to remove the suicidal thoughts warning from GLP-1 weight-loss labels after reviewing 91 trials involving 107,910 patients. That review found no increased risk, but the FDA still asks patients to report new or worsening depression, suicidal thoughts, or unusual changes in mood or behavior to a health professional. FDA labels for semaglutide (Ozempic and Wegovy) advise stopping at least two months before a planned pregnancy. For tirzepatide sold as Zepbound, the label tells prescribers to stop it when pregnancy is recognized. The Zepbound label warns that oral birth control pills may work less well after starting and after each dose increase. It calls for a non-pill or barrier method for four weeks after each of those changes.
For a medicine mistake, get medical help or use the Poison Control tool at poison.org. MedWatch is for reporting problems. You can report side effects or bad vials to FDA MedWatch on consumer Form 3500B. Health professionals use Form 3500.
Handling Myths vs Package Inserts
Check the facts on fridge rules, open vials, and birth control pills.
Myth: Every peptide vial goes in the fridge before opening
NIH lists fridge storage at 36°F to 46°F for semaglutide pens. Egrifta SV’s label gives room temperature, 68°F to 77°F, for unopened vials.
Myth: A punctured multi-dose vial stays clean until the last drop is gone months later
FDA’s general advice is to discard a sterile multi-dose vial within 28 days of first use, even with medicine left or longer compounder instructions.
Myth: Semaglutide and tirzepatide have the exact same birth control and pregnancy rules
Semaglutide labels call for stopping at least two months before a planned pregnancy. The Zepbound label calls for four weeks of non-pill or barrier birth control after the first dose and again after every dose increase.